Bactiguard Competitors and Similar CompaniesClear all

Bactiguard's competitors and similar companies include Enzymatica, Cardionomic, Esperto Medical and Omini.

	Bactiguard Bactiguard, a medtech company, develops and provides infection prevention solutions.	Enzymatica Enzymatica is a life science company that develops and sells medical devices for infection-related diseases.	Cardionomic Cardionomic is a company that provides cardiac treatments intended to be used for treating acute decompensated heart failure.	Esperto Medical Esperto Medical is a company that develops vital sign monitoring technologies.	Omini Omini is a company developing point-of-care lab-on-chip devices for immediate blood tests.
Founding Date	Founding Date 2005	Founding Date 2007	Founding Date 2011	Founding Date 2018	Founding Date 2019
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare fitness & wellness life sciences medical devices	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Technology healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech
Locations	Locations Botkyrka, SE HQ	Locations Lund, SE HQ Reykjavík, IS	Locations Saint Paul, US HQ	Locations Irvine, US HQ	Locations HQ
Employees	Employees 147	Employees 21	Employees 4	Employees 129% increase	Employees 526% increase
Valuation ($)	Valuation ($) 139.7 m	Valuation ($) 40.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr215.9m (FY, 2025)	Revenue (est.) kr53.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr31.3m (FY, 2025)	Cost of goods kr18.8m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr194.3m (FY, 2025)	Gross profit kr36.4m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income (kr7.8m) (FY, 2025)	Net income (kr51.9m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 14.9m	Total funding raised N/A	Total funding raised $ 44.8m	Total funding raised N/A	Total funding raised N/A